← Research library

Efficacy of cortexin in the treatment of memory disorders in children

Comparison in people · 2011

What was studied
60 children with memory disorders
Main finding
Compared Cortexin with encephabol and reported changes on neuropsychological and neurophysiological measures.

Improvement rate · 86.7% versus 63.3% · Group sizes 30/30; numerical neuropsychological score changes not given

Reported findings and study design

60 children aged 7–12 with memory disorders: Cortexin 30 versus Encephabol 30.

Population or model 60 children with memory disorders

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Improvement rate86.7% versus 63.3%Group sizes 30/30; numerical neuropsychological score changes not given

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Active comparator; allocation and masking unclear from the abstract.
  • Pediatric clinical findings do not establish enhancement or safety in healthy adults.

Source details

Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.

Sources checked

Citation

Human comparative studyEnglish abstract

Chutko LS, Surushkina SIu, Iakovenko EA, Bykova IuL, Nikishena IS. Efficacy of cortexin in the treatment of memory disorders in children Zh Nevrol Psikhiatr Im S S Korsakova 111(9 Pt 2):37-40. PMID 22027605

Study source ↗ · DOI 10.1007/s11055-013-9721-4 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards